VX1 Analysis

Vertex Pharmaceuticals Incorporated
Stock Exchange: XETRA
Sector: biotechnology
219.25
Last session price
219.25
Price now
Currency: EUR
Reporting currency: USD
ISIN: US92532F1003
INN:
.

VX1 financial statements

* Numbers in millions
Capitalization * 53 488
EV * 49 521
Number of shares * 260
EPS 10,44
Revenue * 6 206
Net income * 2 712
Operating profit * 2 869
Total liabilities * 3 065
Net debt * 581
Total assets * 11 752
Equity * 8 687
Cash and investments * 6 659
.

VX1 valuation

P/E 19,73
P/B 6,16
P/S 8,62
E/P 5
P/FCF 17,87
.

VX1 profitability

ROE 31%
ROA% 26%
ROIC% 28%